Interest Groups Steering Committee

Chair: Yingyao Chen (China)

Members:

Assessment of Vaccines Programs, Mondher Toumi (France)
Assessment of Vaccines Programs, Christelle Saint Sardos (France)
Assessment of Vaccines Programs, Silvie Jerabkova (Czech Republic) Coordinator
Disinvestment and Early Awareness, Julie Polisena (Canada)
Disinvestment and Early Awareness, Vigdis Lauvrak (Norway)
Early Career Network, Denny John (India)
Early Career Network, Maoling Wei (China)
Ethics and HTA, Ken Bond (Canada)
Ethics and HTA, Dario Sacchini (Italy)
HTA in Developing Countries, Rabia Kahveci (Turkey)
HTA in Developing Countries, Paulo Picon (Brazil)
Hospital-based HTA, Americo Cicchetti (Italy)
Hospital-based HTA, Marco Marchetti (Italy)
Initiative for Public Health Outcomes Research & Measurement, Irene Lenoir-Wijnkoop (the Netherlands)Initiative for Public Health Outcomes Research & Measurement, Iñaki Gutierrez Ibarluzea (Spain)
Information Retrieval Group, Ingrid Harboe (Norway)
Information Retrieval Group, Siw Waffenschmidt (Germany)
Patient and Citizen Involvement, Janet Wale (Australia)
Patient and Citizen Involvement, Neil Bertelsen (United Kingdom)
Regulatory Interactions & Conditional Coverage, Massoud Toussi (France)
Regulatory Interactions & Conditional Coverage, Michelle Mujoomdar (Netherlands/Canada)

Observers:

HTAi Executive Director, Daniel Lalonde (Canada)

HTAi Secretariat, Rebecca Trowman (Australia)

HTAi Secretariat, Katelyn Pretzlaff (Canada)


Terms of Reference

Chair: The Committee will be chaired by HTAi’s Vice President. If the Vice Presidency is vacant or the Vice President is unable to fill this role, the Committee will be chaired by the immediate Past President.

Members: The committee will consist of at least two members of the Society, excluding the Chair. Committee members should be board members or current leaders/representatives of existing Interest Groups and should be familiar with IG structures and governance. Members may be nominated by the Chair, Board of Directors, or Executive Committee, and are ratified by the Board of Directors.

Term of Appointment: Two years, except for the Chair whose term shall coincide with his/her term as Vice President.

Responsibility/Authority: The Committee’s mandate is to make recommendations to the Board of Directors concerning issues related to IG governance and funding and to act as a liaison between IGs and the Board. Issues within the scope of the Committee’s mandate include: Making recommendations to the Board of Directors concerning issues related to IG governance and funding and to act as a liaison between the IGs and the Board.

IG accountability to the Board of Directors

Funding for IG activities (levels, criteria, request/approval processes)

IG internal governance (mandate, structure, membership)

Release of IG publications

Frequency of Meetings: Quarterly or at the call of the Chair.